Morris Paul N, Dunmore Benjamin J, Tadros Amir, Marchuk Douglas A, Darland Diane C, D'Amore Patricia A, Brindle Nicholas P J
Department of Cardiovascular Sciences, University of Leicester, RKCSB, P.O. Box 65, Leicester, LE2 7LX, UK.
J Mol Med (Berl). 2005 Jan;83(1):58-63. doi: 10.1007/s00109-004-0601-9. Epub 2004 Oct 29.
Tie2 is expressed predominantly in endothelial cells and is required for blood vessel formation and maintenance. A missense mutation resulting in an R to W substitution in the kinase domain of Tie2 co-segregates with an autosomal dominantly inherited form of vascular dysmorphogenesis, venous malformation (VM). The mechanism by which this activating mutation leads to vessel dysmorphogenesis in VM is not known. Here we examined Tie2 activation status in VM and found activated receptor in lesional and non-lesional vessels. To gain insight into functional effects of VM mutant Tie2, wild-type and R849W mutant receptor were expressed in cultured human venous endothelial cells. Mutant Tie2 was constitutively phosphorylated in endothelial cells in vivo and caused a marked suppression of apoptosis. The anti-apoptotic kinase Akt was constitutively activated in cells expressing mutant receptor. Dominant-negative Akt inhibited the pro-survival activity of mutant Tie2. Migration of smooth muscle cells induced by conditioned medium from cells expressing mutant receptor was similar to that from cells expressing wild-type receptor. These data suggest that a primary effect of R849W Tie2 in VM is to allow survival of mural cell poor vessels via ligand-independent Tie2 activation of Akt and endothelial survival, rather than to directly induce formation of dysmorphogenic vessels.
Tie2主要在内皮细胞中表达,是血管形成和维持所必需的。一种错义突变导致Tie2激酶结构域中的R被W取代,该突变与常染色体显性遗传形式的血管发育异常——静脉畸形(VM)共分离。这种激活突变导致VM中血管发育异常的机制尚不清楚。在此,我们检测了VM中Tie2的激活状态,发现在病变血管和非病变血管中均有激活的受体。为深入了解VM突变型Tie2的功能效应,在培养的人静脉内皮细胞中表达了野生型和R849W突变型受体。突变型Tie2在体内内皮细胞中持续磷酸化,并显著抑制细胞凋亡。抗凋亡激酶Akt在表达突变型受体的细胞中持续激活。显性负性Akt抑制突变型Tie2的促生存活性。表达突变型受体的细胞条件培养基诱导的平滑肌细胞迁移与表达野生型受体的细胞相似。这些数据表明,VM中R849W Tie2的主要作用是通过Akt的配体非依赖性Tie2激活和内皮细胞存活,使壁细胞缺乏的血管得以存活,而不是直接诱导发育异常血管的形成。